When patients with chronic illness like sickle cell disease or cancer also test positive for COVID-19, they still need access to their intravenous medicines. Similarly, people who are participating in ...
The dominance of the Delta strain of COVID-19 combined with Alabama’s low vaccination rate has led experts to turn to monoclonal antibody infusion, a treatment in which infected individuals are ...
CENTER CITY (WPVI) -- Jefferson University Hospital's Sidney Kimmel Cancer Center will begin tests soon on a new type of COVID-19 drug. It's based on disease-fighting T-cells, drawn from healthy ...
During the COVID-19 pandemic, it quickly became clear that certain populations were particularly at risk for severe disease. Individuals undergoing hematopoietic cell transplants (HCT) or chimeric ...
A newly approved treatment with some history of success could offer hope for the sickest of the country’s COVID-19 patients. The U.S. Food and Drug Administration has approved the use of convalescent ...
The IDSA released 2025 guidelines for treating mild to moderate COVID-19, emphasizing risk-based antiviral use to prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results